Kangmei Pharma | 600518 - Current Liabilities

Stock Price
1.72
Daily Change
0 0%
Monthly
-2.82%
Yearly
-11.79%
Q2 Forecast
1.71

Kangmei Pharma reported CNY5.81B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Genomma Lab Internacional MXN 7.23B 254.33M Dec/2025
Hypermarcas BRL 4.11B 849.68M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Jiangsu Hengrui CNY 5.64B 732.51M Mar/2026
Kangmei Pharma CNY 5.81B 57.93M Sep/2025
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Sh Fosun Pharma CNY 36.42B 1.34B Dec/2025
Tectonic Therapeutic USD 9.67M 293K Dec/2025
Viatris USD 7.09B 269.8M Dec/2025
Wuxi Apptec CNY 19.24B 202.99M Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025
Zz Pientze Pharmaceu CNY 2.14B 1.06B Sep/2025